Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 9 min ago
Peer-reviewedCC BYAdvanced Science

Advancing Biotherapeutic Treatment of Ulcerative Colitis Using Lipid Mesophases: Formulation Design and Preclinical Validation

2 more authors
4 affiliations
  1. 1University of Bern
  2. 2University Hospital Zurich University of Zurich
  3. 3ETH Zurich
  4. 4University of Applied Sciences and Arts Northwestern Switzerland

Related

  1. Therapeutic Potential of Propolis in Ulcerative Colitis: A Review of Preclinical Evidence.
    Thayná Fernandes Barros, Gabriel Gomes Vila Nova, Rosane Nassar Meireles Guerra +2
    Chemistry & biodiversityPeer-reviewedCC BYFull textZoology & animal behaviourEurope PMCPMC
  2. From Salvia dumetorum Hydroethanolic Extract to Tablet Formulation: Integrated Phytochemical, Biological, and Preclinical Safety Evaluation
    Yana K. Levaya, Karakoz Zh. Badekova, Gulnissa K. Kurmantayeva +7
    MoleculesPeer-reviewedCC BY 4.0Plant biologyCrossref
  3. From Formulation Quality to Anti-Tumor Immunity: A Multimodal Imaging and Translational Framework for mRNA–Lipid Nanoparticle Cancer Vaccines in Preclinical Tumor Models
    Alaa A. A. Aljabali, Mohammad A. Obeid, Abdelrahim Alqudah +2
    BiomoleculesPeer-reviewedCC BY 4.0General biochemistryCrossref
  4. Multi-cohort meta-analysis, single-cell and Mendelian randomization analyses with experimental validation identify RHBDF2 as a shared mediator of ulcerative colitis and blood-brain barrier disruption.
    Jiongjiong Cheng, Aman Xu
    Frontiers in synaptic neurosciencePeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  5. A Stream-Function Formulation for the Surface Stokes-Helfrich Model - Surface Finite Element Discretization and Validation
    Enno Igel, Maik Porrmann, Axel Voigt
    arXivPreprintarXiv licenceFull textNumerical analysis & scientific computingarXiv
BibTeX
@article{gazzi2026advancing,
  title = {{Advancing Biotherapeutic Treatment of Ulcerative Colitis Using Lipid Mesophases: Formulation Design and Preclinical Validation}},
  author = {Rafaela Gazzi and Tiziana Cremona and Reto Czekalla and Emily Campbell and Marlene Schwarzfischer and Doris Pöhlmann and Vanessa Dobernig and Gerhard Rogler and Michael Scharl and Alessandra Bergadano and Raffaele Mezzenga and Martin Kuentz and Paola Luciani and Simone Aleandri},
  journal = {Advanced Science},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655260},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Advancing Biotherapeutic Treatment of Ulcerative Colitis Using Lipid Mesophases: Formulation Design and Preclinical Validation
AU  - Rafaela Gazzi
AU  - Tiziana Cremona
AU  - Reto Czekalla
AU  - Emily Campbell
AU  - Marlene Schwarzfischer
AU  - Doris Pöhlmann
AU  - Vanessa Dobernig
AU  - Gerhard Rogler
AU  - Michael Scharl
AU  - Alessandra Bergadano
AU  - Raffaele Mezzenga
AU  - Martin Kuentz
AU  - Paola Luciani
AU  - Simone Aleandri
PY  - 2026
DA  - 2026/10/11
JO  - Advanced Science
UR  - https://europepmc.org/article/PMC/PMC13655260
SN  - 2198-3844
ER  -